🔴 Gyre Therapeutics is trading 5% down in after-hours trading with no clear company-specific catalyst

Gyre Therapeutics is trading 5.22% lower at $6.72, with no clear company-specific announcement identified to explain the after-hours decline.

• It closed at $7.09 on October 28.
• The latest company release listed on its investor-relations site predates this move.
• Supplied market context is mixed and does not establish a broader-market reason. The decline follows two consecutive regular-session gains, which do not explain the after-hours move.